|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | 3-Bromopyruvic acid, 3-Bromopyruvate, Hexokinase II Inhibitor II | Storage (From the date of receipt) |
3 years -20°C powder | |||||||||||
| 化学式 | C3H3BrO3 |
||||||||||||||
| 分子量 | 166.96 | CAS No. | 1113-59-3 | ||||||||||||
| Solubility (25°C)* | 体外 | DMSO | 33 mg/mL (197.65 mM) | ||||||||||||
| Water | 33 mg/mL (197.65 mM) | ||||||||||||||
| Ethanol | 33 mg/mL (197.65 mM) | ||||||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||||||
| 製品説明 | ブロモピルビン酸 (3-BP) は、解糖系/ヘキソキナーゼ阻害に対する Ki 2.4 mM を持つヘキソキナーゼ II 阻害剤です。これは腫瘍細胞エネルギー代謝の阻害剤であり、白金製剤の化学増強剤です。 |
|---|---|
| in vitro | Bromopyruvic acid, a glycolysis inhibitor, maintains haploidy to a certain extent in both OdG and EG1 haESCs, with no effect on the proliferation or pluripotency of the haESCs. |
| in vivo | Bromopyruvic acid reduces the growth of RKO cells with CD36 knockdown at a significantly slower rate in xenograft model. |
| 細胞アッセイ | 細胞株 | Mouse haESC lines AGH-OG-3 and AGH-EG-1 |
|---|---|---|
| 濃度 | 12.5 μg/mL | |
| 反応時間 | 12 days | |
| 実験の流れ | Mouse haESC lines AGH-OG-3 and AGH-EG-1 were cultured in M2iL mediums, which containing knockout DMEM, 15% fetal bovine serum, 1% GlutaMAX, 1% nonessential amino acids, 100 μM β-mercaptoethanol, 100 U Leukemia inhibitory factor, 3 μM CHIR99021, and 1 μM PD0325901. The cells are cultured at 37 ℃ with 5% CO2 in a humidified environment. 1,25-(OH)2D3 and 3-BrPA are used at a final concentration of 12.5 μg/mL and 5μM, respectively. |
|
| 動物実験 | 動物モデル | 4-week-old nude mice injected with RKO cells |
| 投薬量 | 5 mg/kg/day | |
| 投与方法 | i.p. |
|
| The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer [ Signal Transduct Target Ther, 2025, 10(1):341] | PubMed: 41083431 |
| Photobiomodulation modulates mitochondrial energy metabolism and ameliorates neurological damage in an APP/PS1 mousmodel of Alzheimer's disease [ Alzheimers Res Ther, 2025, 17(1):72] | PubMed: 40188044 |
| GL-V9 inhibits the activation of AR-AKT-HK2 signaling networks and induces prostate cancer cell apoptosis through mitochondria-mediated mechanism [ iScience, 2024, 27(3):109246] | PubMed: 38439974 |
| Hexokinase 2 nonmetabolic function-mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression [ Cancer Sci, 2024, 10.1111/cas.16204] | PubMed: 38801832 |
| METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells [ EMBO Rep, 2023, e56325.] | PubMed: 36794620 |
| 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis [ Cancer Gene Ther, 2023, 10.1038/s41417-023-00648-5] | PubMed: 37558749 |
| ASPP2 suppresses tumour growth and stemness characteristics in HCC by inhibiting Warburg effect via WNT/β-catenin/HK2 axis [ J Cell Mol Med, 2023, 27(5):659-671] | PubMed: 36752127 |
| Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance [ Nat Metab, 2022, 4(10):1287-1305] | PubMed: 36203054 |
| Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC [ Hepatology, 2022, 75(6):1386-1401] | PubMed: 34580888 |
| Inhibition of abnormally activated HIF-1α-GLUT1/3-glycolysis pathway enhances the sensitivity of hepatocellular carcinoma to 5-caffeoylquinic acid and its derivatives [ Eur J Pharmacol, 2022, S0014-2999(22)00105-4] | PubMed: 35189090 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。